Topics

AstraZeneca cancer drug combo meets late-stage trial goal

07:53 EDT 28 Oct 2019 | Reuters

AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.

Original Article: AstraZeneca cancer drug combo meets late-stage trial goal

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca cancer drug combo meets late-stage trial goal"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...